Latent Herpesvirus 8 infection improves both insulin and glucose uptake in primary endothelial cells

New Microbiologica

Volumn 36, Issue 3, 2013, Pages 257-265

  Ingianni, Angela ^a   Piras, Enrica ^a   Laconi, Samuela ^a   Angius, Fabrizio ^a   Batetta, Barbara ^a   Pompei, Raffaello ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cell metabolism; Cell host interaction; Insulin uptake; Latent viral infection

Indexed keywords

ANTIDIABETIC AGENT; DEOXYGLUCOSE; GLUCOSE; INSULIN; INSULIN RECEPTOR; TRITIUM;

ARTICLE; CELL CULTURE; CYTOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TRANSPORT AT THE CELLULAR LEVEL; VIROLOGY; VIRUS LATENCY;

BIOLOGICAL TRANSPORT; CELLS, CULTURED; DEOXYGLUCOSE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; GLUCOSE; HERPESVIRUS 8, HUMAN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PROTEIN BINDING; RECEPTOR, INSULIN; SARCOMA, KAPOSI; TRITIUM; VIRUS LATENCY;

EID: 84883156280     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ABLASHI D.V., CHATLYNNE L.G., WHITMAN G.E. JR, CESARMAN E. (2002). Spectrum of Karposi's sarcoma- associated Herpesvirus, or Human Herpesvirus 8, diseases. Clin. Microbiol. Rev. 15, 439-464.
2. CARROLL P.A., KENERSON H.L., YEUNG R.S., LAGUNOFF M. (2006). Latent Kaposi's sarcoma-associated Herpesvirus infection of endothelial cells activate hypoxia-induced factors. J. Virol. 80, 10802-10812.
3. CASELLI E., FIORENTINI S., AMICI C., DI LUCA D., CARUSO A., SANTORO M.G. (2007). Human Herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary- like structure formation: role of the IKK/NF-kB pathway. Blood 109, 2718-2726.
4. CERIMELE F., CURRELI F., ELY S., FRIEDMAN-KIEN A.E., CESARMAN E., FLORE O. (2001). Kaposi's sarcoma-associated Herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J. Virol. 75, 2435-2443.
5. DELGADO T., CARROLL P.A., PUNJABI A.S., MARGINEANTU D., HOCKENBERY D.M., LAGUNOFF M. (2010). Induction of the Warburg effect by Kaposi's sarcoma Herpesvirus is required for the maintenance of latently infected endothelial cells. PNAS. 107 (23), 10696-10701.
6. DOUGLAS J.L., GUSTIN J.K., VISWANATHAN K., MANSOURI M., MOSES A.V., FRUH K. (2010). The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6, 1-12.
7. DOURMISHEV L.A., DOURMISHEV A.L., PALMERI D., SCHWARTZ R.A., LUKAC D.A. (2003). Molecular genetics of Kaposi's sarcoma-associated Herpesvirus (Human Herpesvirus 8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 175-212.
8. GANEM D. (2010). KSHV and the pathogenesis of Kaposi's sarcoma: listening to human biology and medicine. J. Clin. Invest. 120, 939-949.
9. GREGORY S.M., WANG L., WEST J.A., DITTMER D.P., DAMANIA B. (2012). Latent KSHV infection of monocytes downregulates expression of adaptive immunity response costimulatory receptors and proinflammatory cytokine expression. J. Virol. 86, 3916-3923.
10. GUILLUY C., ZHANG Z., BHENDE P.M., SHAREK L., WANG L., BURRIDGE K., DAMANIA B. (2011). Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood. 118, 5344-5354.
11. HENGGE U.R., RUZICKA T., TYRING S.K., STUSCHKE M., ROGGENDORFM., SCHWARTZ R.A., SEEBER S. (2002). Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet. Infect. Dis. 2, 281-292.
12. INGIANNI A., CARTA F., REINA A., MANAI M., DESOGUS A., POMPEI R. (2007). Prevalence of Herpesvirus 8 infection in type 2 diabetes mellitus patients. Am. J. Infect. Dis. 3, 123-127.
13. INGIANNI A., MADEDDU M.A., CARTA F., REINA A., LAI C., POMPEI R. (2009). Epidemiology of Human Herpesvirus type 8 infection in cardiopathic patients. Online J. Biol. Sci. 9, 36-39.
14. MCALLISTER S.C., MOSES A.V. (2007). Endothelial celland lymphocyte-based in vitro systems for understanding KSHV biology. Curr. Top. Microbiol. Immunol. 312, 211-244.
15. NGUYEN M.T., SATOH H., FAVELYUKIS S., BABENDURE J.L., IMAMURA T., SBODIO J.L., ZALEVSKY J., DAHIYAT B.I., CHI N.W., OLEFSKY J.M. (2005). JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280, 35361-35371.
16. OTTENSMEYER F.P., BENIAC D.R., LUO R.Z., YIP C.C. (2000). Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry. 39, 2103-2112.
17. PARRAVICINI C., CHANDRAN B., CORBELLINO M., BERTI E., PALLI M., MOORE P.S., CHANG Y. (2000). Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156, 743-749.
18. RAGGO C., RUHL R., MCALLISTER S., KOON H., DEZUBE B.J., FRUH K., MOSES A.V. (2005). Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res. 65, 5084-5095.
19. ROSE P.P., CARROLL J.M., CARROLL P.A., DEFILIPPIS V.R., LAGUNOFF M., MOSES A.V., ROBERTS C.T. JR., FRUH K. (2007). The insulin receptor is essential for virusinduced tumorigenesis of Kaposi's sarcoma. Oncogene. 26, 1995-2005.
20. STUBER G., MATTSSON K., FLABERG E., KATI E., MARKASZ L., SHELDON J.A., KLEIN G., SCHULZ T.F., SZELEKY L. (2007). HHV-8 encoded LANA-1 alters the high organization of the cell nucleus. Mol. Cancer. 6, 28-33.
21. WANG H.W., TROTTER M.W., LAGOS D., BOURBOULIA D., HENDERSON S., MAKINEN T., ELLIMAN S., FLANAGAN A.M., ALITALO K., BOSHOFF C. (2004). Kaposi sarcoma herpesvirus-induced cellular programming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36, 687-693.
22. WANG L., DAMANIA B. (2008). Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cell. Cancer Res. 68, 4640-4648.
23. WATANABE T., SUGAYA M., ATKINS A.M., AQUILINO E.A., YANG A., BORRIS D.L., BRADY J., BLAUVELT A. (2003). Kaposi's sarcoma-associated herpesvirus latencyassociated nuclear antigen prolongs the life span of primary umbilical vein endothelial cells. J. Virol. 77, 6188-6196.
24. WEN K.W., DAMANIA B. (2010). Kaposi's sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 28, 140-150.